J&J Adds To Robotic Focus With French Firm Acquisition
Executive Summary
Johnson & Johnson has purchased Orthotaxy, a French developer of software-based surgical technologies. The company is developing a surgical robot that could be used for knee replacements.
You may also be interested in...
Exec Chat: J&J DePuy Synthes’ Sharrolyn Josse Outlines Strategy For VELYS Digital Surgery
In an interview with Medtech Insight, Sharrolyn Josse, worldwide president of VELYS Digital Surgery and Capital at Johnson & Johnson’s DePuy Synthes unit, outlines strategies that are driving the present and future VELYS robotic-assisted solution and its connected technologies.
J&J Bullish On Procedure Recovery As Q2 Device Sales Beat Analyst Expectations
Johnson & Johnson management said they expect medical device sales to make a quick recovery in the third and fourth quarter of 2020 after seeing a faster-than-expected reuptake of procedures during the second quarter.
J&J Takes Full Ownership Of Verb Surgical, Verily Breaks Off Robotics Partnership
Johnson & Johnson is acquiring the remaining stake in Verb Surgical from Verily following a four-year partnership. The transaction is expected to close in the first half of 2020.